Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119474709> ?p ?o ?g. }
- W3119474709 endingPage "178" @default.
- W3119474709 startingPage "164" @default.
- W3119474709 abstract "Objective: Methylphenidate (MPH) is efficacious in reducing symptoms of attention-deficit/hyperactivity disorder (ADHD), but there are no data about the efficacy and safety of its new formulation (ORADUR®-MPH extended release, ORADUR-MPH) in patients with ADHD, which is the study objective. Method: This was a Phase III, multicenter, randomized, double-blind, placebo-controlled, two-way crossover clinical trial. One hundred children and adolescents with a clinical diagnosis of ADHD (72.7% male) received at least one dose of ORADUR-MPH or a placebo during the 2-week treatment period of each phase. The primary efficacy measure was the Swanson, Nolan, and Pelham-IV-teacher (SNAP-IV-T) form. Secondary efficacy measures included the SNAP-IV-parent form, the Clinical Global Impression: ADHD-Severity score, the Conner's Teacher's Rating Scale score, and the investigator's rating for 18 Diagnostic and Statistical Manual of Mental Disorders, 5th edition ADHD symptoms. In addition, data related to vital signs, body weight, physical examination, laboratory testing, and adverse events (AEs) were also collected. All data were analyzed on an intent-to-treat basis. Results: Without adjusting for differences in demographics and baseline measures, both treatment groups showed significant reductions in ADHD and oppositional defiant disorder symptoms after a 2-week treatment with greater effect sizes (Cohen's d) in the ORADUR-MPH group (Cohen's d ranging from -0.41 to -1.64; placebo, Cohen's d ranging from -0.26 to -1.18), except for oppositional symptoms, regardless of the informants. For the primary efficacy measure, ORADUR-MPH was significantly superior to the placebo, as evidenced by lower values for and greater reductions in the SNAP-IV-T scores at the endpoint (Cohen's d = -0.16, p = 0.005) and from baseline to the endpoint (Cohen's d = -0.19, p = 0.006), respectively. There were no serious AEs during the clinical study period. The most frequently observed AE was decreased appetite (49.1%). Most physical and laboratory test variables remained within the normal range. Conclusions: Once-daily ORADUR-MPH is an effective, well-tolerable, and safe treatment for children and adolescents with ADHD. ClinicalTrials.gov number, NCT02450890." @default.
- W3119474709 created "2021-01-18" @default.
- W3119474709 creator A5017449487 @default.
- W3119474709 creator A5058621424 @default.
- W3119474709 creator A5068381295 @default.
- W3119474709 creator A5069374406 @default.
- W3119474709 creator A5087181752 @default.
- W3119474709 date "2021-04-01" @default.
- W3119474709 modified "2023-09-29" @default.
- W3119474709 title "A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder" @default.
- W3119474709 cites W1155786771 @default.
- W3119474709 cites W1449657760 @default.
- W3119474709 cites W1524526058 @default.
- W3119474709 cites W1562373344 @default.
- W3119474709 cites W1564761171 @default.
- W3119474709 cites W1650128610 @default.
- W3119474709 cites W1850821928 @default.
- W3119474709 cites W1966048968 @default.
- W3119474709 cites W1968752176 @default.
- W3119474709 cites W1969779240 @default.
- W3119474709 cites W1973440222 @default.
- W3119474709 cites W1973681283 @default.
- W3119474709 cites W1979464170 @default.
- W3119474709 cites W1989432790 @default.
- W3119474709 cites W1989649280 @default.
- W3119474709 cites W1990010425 @default.
- W3119474709 cites W1991933160 @default.
- W3119474709 cites W1993315662 @default.
- W3119474709 cites W1998962049 @default.
- W3119474709 cites W2001684189 @default.
- W3119474709 cites W2003927165 @default.
- W3119474709 cites W2007312830 @default.
- W3119474709 cites W2012989506 @default.
- W3119474709 cites W2016499495 @default.
- W3119474709 cites W2025431637 @default.
- W3119474709 cites W2030460171 @default.
- W3119474709 cites W2033703462 @default.
- W3119474709 cites W2035768785 @default.
- W3119474709 cites W2042378780 @default.
- W3119474709 cites W2044451720 @default.
- W3119474709 cites W2063772783 @default.
- W3119474709 cites W2065636703 @default.
- W3119474709 cites W2071199156 @default.
- W3119474709 cites W2084187081 @default.
- W3119474709 cites W2087584801 @default.
- W3119474709 cites W2088606503 @default.
- W3119474709 cites W2091106851 @default.
- W3119474709 cites W2091366608 @default.
- W3119474709 cites W2092284286 @default.
- W3119474709 cites W2097467510 @default.
- W3119474709 cites W2097767249 @default.
- W3119474709 cites W2102780372 @default.
- W3119474709 cites W2110369201 @default.
- W3119474709 cites W2117744335 @default.
- W3119474709 cites W2122837915 @default.
- W3119474709 cites W2123050269 @default.
- W3119474709 cites W2132060736 @default.
- W3119474709 cites W2132430593 @default.
- W3119474709 cites W2136697574 @default.
- W3119474709 cites W2137070227 @default.
- W3119474709 cites W2144829238 @default.
- W3119474709 cites W2147033404 @default.
- W3119474709 cites W2148978240 @default.
- W3119474709 cites W215048894 @default.
- W3119474709 cites W2153007969 @default.
- W3119474709 cites W2171785923 @default.
- W3119474709 cites W2266642035 @default.
- W3119474709 cites W2278685906 @default.
- W3119474709 cites W2290117951 @default.
- W3119474709 cites W2391879726 @default.
- W3119474709 cites W2400966861 @default.
- W3119474709 cites W2407101920 @default.
- W3119474709 cites W2547622173 @default.
- W3119474709 cites W2581009200 @default.
- W3119474709 cites W2605935290 @default.
- W3119474709 cites W2611352611 @default.
- W3119474709 cites W2614669943 @default.
- W3119474709 cites W2617239090 @default.
- W3119474709 cites W2619117901 @default.
- W3119474709 cites W2626181987 @default.
- W3119474709 cites W2735004895 @default.
- W3119474709 cites W2736126009 @default.
- W3119474709 cites W2738856406 @default.
- W3119474709 cites W2742610316 @default.
- W3119474709 cites W274764465 @default.
- W3119474709 cites W2763907737 @default.
- W3119474709 cites W2783849769 @default.
- W3119474709 cites W2794227021 @default.
- W3119474709 cites W2799757909 @default.
- W3119474709 cites W2802815532 @default.
- W3119474709 cites W2804891109 @default.
- W3119474709 cites W2810775064 @default.
- W3119474709 cites W2811154889 @default.
- W3119474709 cites W2886298463 @default.
- W3119474709 cites W2889164119 @default.
- W3119474709 cites W2901188280 @default.
- W3119474709 cites W2929047355 @default.
- W3119474709 cites W2945126729 @default.